Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioffe

Showing results (601-610 of 629) with videos related to

Pageof 63
Sort By:
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
International Journal of Oncology|December 17, 2008
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockadeJianzhong Huang, Jae-O Bae, Judy P Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology TrialMatthew A Powell, Virginia L Filiaci, Martee L Hensley, et al.
JCI Insight|October 31, 2023
Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiencyGatikrushna Panigrahi, Julián Candia, Tiffany H Dorsey, et al.
Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Nature Structural Biology|December 7, 2002
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclusteringSamuel Davis, Nick Papadopoulos, Thomas H Aldrich, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Chemistry, an Asian Journal|March 11, 2017
Tightly Bound Double-Caged [60]Fullerene Derivatives with Enhanced Solubility: Structural Features and Application in Solar CellsVictor A Brotsman, Vitaliy A Ioutsi, Alexey V Rybalchenko, et al.
JNCI Cancer Spectrum|April 28, 2020
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)Phuong L Mai, Austin Miller, Mitchell H Gail, et al.
Journal of Applied Crystallography|June 14, 2018
The high-intensity reflectometer of the Jülich Centre for Neutron Science: MARIAStefan Mattauch, Alexandros Koutsioubas, Ulrich Rücker, et al.
Pageof 63

Showing results (601-610 of 629) with videos related to

Sort By:
Pageof 63
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
International Journal of Oncology|December 17, 2008
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockadeJianzhong Huang, Jae-O Bae, Judy P Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology TrialMatthew A Powell, Virginia L Filiaci, Martee L Hensley, et al.
JCI Insight|October 31, 2023
Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiencyGatikrushna Panigrahi, Julián Candia, Tiffany H Dorsey, et al.
Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Nature Structural Biology|December 7, 2002
Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclusteringSamuel Davis, Nick Papadopoulos, Thomas H Aldrich, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Chemistry, an Asian Journal|March 11, 2017
Tightly Bound Double-Caged [60]Fullerene Derivatives with Enhanced Solubility: Structural Features and Application in Solar CellsVictor A Brotsman, Vitaliy A Ioutsi, Alexey V Rybalchenko, et al.
JNCI Cancer Spectrum|April 28, 2020
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)Phuong L Mai, Austin Miller, Mitchell H Gail, et al.
Journal of Applied Crystallography|June 14, 2018
The high-intensity reflectometer of the Jülich Centre for Neutron Science: MARIAStefan Mattauch, Alexandros Koutsioubas, Ulrich Rücker, et al.
Pageof 63